Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agents.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 30 04 2020
accepted: 28 06 2020
pubmed: 29 7 2020
medline: 2 6 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

This study aimed to examine the degradation of tigecycline in Mueller Hinton broth (ca-MHB), as knowledge about bacterial susceptibility is key for therapeutic decisions. Antioxidative stabilizers were evaluated on tigecycline stability in a quantitative chromatography assay and tigecycline induced kill against Staphylococcus aureus (ATCC29213) was determined in time kill studies. Ascorbic acid caused rapid degradation of tigecycline and resulted in loss of antibacterial activity. Tigecycline was stabilized in aged broth by 2% pyruvate and bacterial growth, and tigecycline killing was similar to fresh broth without supplementation, but independent of age. Our results underline the importance of using freshly prepared ca-MHB or the need for stabilizers for tigecycline susceptibility testing while using aged ca-MHB.

Identifiants

pubmed: 32720091
doi: 10.1007/s10096-020-03970-0
pii: 10.1007/s10096-020-03970-0
pmc: PMC7782409
doi:

Substances chimiques

Anti-Bacterial Agents 0
Culture Media 0
Excipients 0
Tigecycline 70JE2N95KR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-218

Références

Antimicrob Agents Chemother. 2005 Sep;49(9):3903-9
pubmed: 16127069
J Antimicrob Chemother. 2005 Dec;56(6):1042-6
pubmed: 16286361
PLoS One. 2014 May 28;9(5):e95281
pubmed: 24871339
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:242-248
pubmed: 27414982

Auteurs

Lisa F Amann (LF)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Bundesstraße 45, DE-20146, Hamburg, Germany.

Emilia Ruda Vicente (ER)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Bundesstraße 45, DE-20146, Hamburg, Germany.

Mareike Rathke (M)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Bundesstraße 45, DE-20146, Hamburg, Germany.

Astrid Broeker (A)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Bundesstraße 45, DE-20146, Hamburg, Germany.

Maria Riedner (M)

Department of Chemistry, University of Hamburg, Martin-Luther-King-Platz 6, 20146, Hamburg, Germany.

Sebastian G Wicha (SG)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Bundesstraße 45, DE-20146, Hamburg, Germany. sebastian.wicha@uni-hamburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH